Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

AMD 473

Known as: AMD-473, AMD473 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2006
Highly Cited
2006
The effect of different N-N spectator ligands on the reactivity of platinum(II) complexes was investigated by studying the water… Expand
  • table 1
  • figure 2
  • figure 1
  • figure 3
  • figure 4
2006
2006
The trinuclear complex: [[trans-PtCl(NH3)](2)mu-[trans-Pd(NH(3))(2-hydroxypyridine)-(H(2)N(CH(2))(6)NH(2))(2)]Cl(4) (code named… Expand
2006
2006
The preparation and oxidation of the anticancer drug AMD473, cis-[PtCl2(NH3)(2-pic)] (2-pic = 2-methylpyridine), has been… Expand
Highly Cited
2005
Highly Cited
2005
Platinum-based chemotherapeutic regimens are ultimately unsuccessful due to intrinsic or acquired drug resistance. Understanding… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
2005
2005
cis-[PtCl2(NH3)(2-picoline)] (AMD473) is currently on clinical trials as an anticancer drug. The trans isomer, AMD443 (1), is… Expand
2003
2003
The syntheses of [PtCl(2)(amp)] (amp = 2-pyridylmethylamine) and enantiomerically pure [PtCl(2)(R-pea)] and [PtCl(2)(S-pea)] (pea… Expand
Highly Cited
2000
Highly Cited
2000
Acquired drug resistance to the sterically hindered platinum drug ZD0473 (formerly known as JM473 and AMD473) and currently being… Expand
Highly Cited
1998
Highly Cited
1998
A novel sterically hindered platinum complex, AMD473 [cis-aminedichloro(2-methylpyridine) platinum (II)], has been selected for… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 6
Highly Cited
1998
Highly Cited
1998
cis-[Amminedichloro(2-methylpyridine)] platinum(II) (AMD473) is a novel sterically hindered anti-tumour compound designed to… Expand
Highly Cited
1997
Highly Cited
1997
A novel sterically hindered platinum complex, AMD473 [cis-amminedichloro(2-methylpyridine) platinum(II)], designed primarily to… Expand
  • figure 1
  • table I
  • table 2
  • table 3
  • figure 2